DSIP (Delta Sleep Inducing Peptide)

DSIP (Delta Sleep Inducing Peptide)

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide under investigation for its potential involvement in regulating sleep, reducing stress, supporting recovery, and maintaining neuroendocrine equilibrium. First identified through research on delta-wave sleep patterns, it is now frequently studied in the context of wellness and physical restoration, particularly for its possible benefits in enhancing sleep depth, promoting relaxation, stabilizing mood, and aiding recovery processes. Interest in DSIP has grown within biohacking and longevity circles due to its suggested influence on cortisol regulation and nervous system repair.

Also known as: Delta Sleep Inducing Peptide, Delta Sleep-Inducing Peptide

• Status: Still under investigation – research findings are inconsistent. Evidence based on human clinical trials.
• Common dosage: 100–250 mcg taken once daily, about 30 minutes before bedtime. Administered via subcutaneous, intramuscular, or intranasal routes.
• Studied primarily for: Improving sleep quality, increasing deep sleep, supporting stress recovery, and regulating circadian rhythm.